MAB9576100
Human CD30/TNFRSF8 (Research Grade Brentuximab Biosimilar) Antibody, R&D Systems™
Manufacturer: Fischer Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | MAB9576100-Each-of-1 | In Stock | ₹ 46,031.28 |
MAB9576100 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,031.28
GST (18%): ₹ 8,285.63
Total Price: ₹ 54,316.91
Antigen
CD30/TNFRSF8
Classification
Monoclonal
Conjugate
Unconjugated
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species
Human
Purification Method
Protein A or G purified from cell culture supernatant
Primary or Secondary
Primary
Test Specificity
Detects human CD30/TNFRSF8 in direct ELISAs. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Brentuximab. This product is for research use only.
Target Species
Human
Form
Supernatant
Applications
Flow Cytometry, CyTOF
Clone
Hu8
Dilution
Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready
Gene Alias
CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, TNFRSF8, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8
Immunogen
Human CD30/TNFRSF8
Quantity
100 μg
Gene ID (Entrez)
943
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype
IgG1
Description
- CD30/TNFRSF8 Monoclonal specifically detects CD30/TNFRSF8 in Human samples
- It is validated for Flow Cytometry, CyTOF-ready.
Compare Similar Items
Show Difference
Antigen: CD30/TNFRSF8
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species: Human
Purification Method: Protein A or G purified from cell culture supernatant
Primary or Secondary: Primary
Test Specificity: Detects human CD30/TNFRSF8 in direct ELISAs. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Brentuximab. This product is for research use only.
Target Species: Human
Form: Supernatant
Applications: Flow Cytometry, CyTOF
Clone: Hu8
Dilution: Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready
Gene Alias: CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, TNFRSF8, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8
Immunogen: Human CD30/TNFRSF8
Quantity: 100 μg
Gene ID (Entrez): 943
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG1
Antigen:
CD30/TNFRSF8
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species:
Human
Purification Method:
Protein A or G purified from cell culture supernatant
Primary or Secondary:
Primary
Test Specificity:
Detects human CD30/TNFRSF8 in direct ELISAs. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Brentuximab. This product is for research use only.
Target Species:
Human
Form:
Supernatant
Applications:
Flow Cytometry, CyTOF
Clone:
Hu8
Dilution:
Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready
Gene Alias:
CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, TNFRSF8, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8
Immunogen:
Human CD30/TNFRSF8
Quantity:
100 μg
Gene ID (Entrez):
943
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG1
Antigen: CD30/TNFRSF8
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species: Human
Purification Method: Protein A or G purified from cell culture supernatant
Primary or Secondary: Primary
Test Specificity: Detects human CD30/TNFRSF8 in direct ELISAs. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Brentuximab. This product is for research use only.
Target Species: Human
Form: Supernatant
Applications: Flow Cytometry, CyTOF
Clone: Hu8
Dilution: Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready
Gene Alias: CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, TNFRSF8, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8
Immunogen: Human CD30/TNFRSF8
Quantity: 25 μg
Gene ID (Entrez): 943
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG1
Antigen:
CD30/TNFRSF8
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species:
Human
Purification Method:
Protein A or G purified from cell culture supernatant
Primary or Secondary:
Primary
Test Specificity:
Detects human CD30/TNFRSF8 in direct ELISAs. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Brentuximab. This product is for research use only.
Target Species:
Human
Form:
Supernatant
Applications:
Flow Cytometry, CyTOF
Clone:
Hu8
Dilution:
Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready
Gene Alias:
CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, TNFRSF8, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8
Immunogen:
Human CD30/TNFRSF8
Quantity:
25 μg
Gene ID (Entrez):
943
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG1
Antigen: EGFR
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species: Human
Purification Method: Protein A or G purified from cell culture supernatant
Primary or Secondary: Primary
Test Specificity: Detects human EGFR based on Cetuximab therapeutic antibody. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Cetuximab. This product is for research use only.
Target Species: Human
Form: Supernatant
Applications: Flow Cytometry, CyTOF
Clone: Hu1
Dilution: Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready
Gene Alias: avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, EC 2.7.10, EC 2.7.10.1, EGF R, epidermal growth factor receptor, epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b)oncogene homolog), ErbB, ErbB1, ERBB1PIG61, HER1, HER-1, mENA, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1
Immunogen: Human EGF R/ErbB1
Quantity: 100 μg
Gene ID (Entrez): 1956
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG1
Antigen:
EGFR
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species:
Human
Purification Method:
Protein A or G purified from cell culture supernatant
Primary or Secondary:
Primary
Test Specificity:
Detects human EGFR based on Cetuximab therapeutic antibody. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Cetuximab. This product is for research use only.
Target Species:
Human
Form:
Supernatant
Applications:
Flow Cytometry, CyTOF
Clone:
Hu1
Dilution:
Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready
Gene Alias:
avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, EC 2.7.10, EC 2.7.10.1, EGF R, epidermal growth factor receptor, epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b)oncogene homolog), ErbB, ErbB1, ERBB1PIG61, HER1, HER-1, mENA, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1
Immunogen:
Human EGF R/ErbB1
Quantity:
100 μg
Gene ID (Entrez):
1956
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG1
Antigen: EGFR
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species: Human
Purification Method: Protein A or G purified from cell culture supernatant
Primary or Secondary: Primary
Test Specificity: Detects human EGFR based on Cetuximab therapeutic antibody. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Cetuximab. This product is for research use only.
Target Species: Human
Form: Supernatant
Applications: Flow Cytometry, CyTOF
Clone: Hu1
Dilution: Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready
Gene Alias: avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, EC 2.7.10, EC 2.7.10.1, EGF R, epidermal growth factor receptor, epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b)oncogene homolog), ErbB, ErbB1, ERBB1PIG61, HER1, HER-1, mENA, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1
Immunogen: Human EGF R/ErbB1
Quantity: 25 μg
Gene ID (Entrez): 1956
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG1
Antigen:
EGFR
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Host Species:
Human
Purification Method:
Protein A or G purified from cell culture supernatant
Primary or Secondary:
Primary
Test Specificity:
Detects human EGFR based on Cetuximab therapeutic antibody. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Cetuximab. This product is for research use only.
Target Species:
Human
Form:
Supernatant
Applications:
Flow Cytometry, CyTOF
Clone:
Hu1
Dilution:
Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready
Gene Alias:
avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, EC 2.7.10, EC 2.7.10.1, EGF R, epidermal growth factor receptor, epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b)oncogene homolog), ErbB, ErbB1, ERBB1PIG61, HER1, HER-1, mENA, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1
Immunogen:
Human EGF R/ErbB1
Quantity:
25 μg
Gene ID (Entrez):
1956
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG1